Millions of migraine sufferers may soon be able to live without their debilitating headaches. An international team of researchers has developed a new migraine vaccine that significantly reduces severe migraine attacks. These headaches are a pain that only those with migraines can truly understand: a strong throbbing sensation and unbearable pain in the head. Every movement and sound worsens the headache, which seems to get worse and worse. When migraines reach this stage, most medications no longer help. In such cases, the only option was to lie down, darken the room, remain quiet, and somehow endure the migraine attack.
The new immunotherapy for migraines, also known as migraine antibody therapy or migraine vaccine, is a passive vaccine that is covered by health insurance. Most people have learned to live with their migraines and can recognize the signs of an impending migraine attack and respond early. However, only rarely can they avoid the severe headaches. Headache tablets, painkillers, or specific migraine medications do not always help, and most people simply endure their migraines. Stress, hormonal fluctuations, fatigue, or weather changes are the most common triggers for migraines. Depending on the person, several tens to 20 migraine attacks per month are not uncommon. This is an immense burden for those affected, which costs a lot of energy and vitality.
The first migraine patients seem to be almost cured, as a new immunotherapy can now help even those who suffer from severe migraines. The new migraine treatment is a type of passive vaccine. The body does not produce antibodies against the inflammatory substances responsible for migraines, but the corresponding antibodies are injected every four weeks. Although the vaccine does not completely cure patients with severe migraines, it significantly reduces headaches. These can then be treated quickly and effectively with simple painkillers, according to the doctors. Medical professionals strongly advise against taking migraines lightly and recommend treating them promptly. According to the German Brain Foundation, only about half of the approximately 10 million migraine patients in Germany receive medical treatment. The new immunotherapy for headaches is very well tolerated and is covered by health insurance.
